Identification of key genes for diabetic kidney disease using biological informatics methods
- PMID: 28990106
- PMCID: PMC5779875
- DOI: 10.3892/mmr.2017.7666
Identification of key genes for diabetic kidney disease using biological informatics methods
Abstract
Diabetic kidney disease (DKD) is a common complication of diabetes, which is characterized by albuminuria, impaired glomerular filtration rate or a combination of the two. The aim of the present study was to identify the potential key genes involved in DKD progression and to subsequently investigate the underlying mechanism involved in DKD development. The array data of GSE30528 including 9 DKD and 13 control samples was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) in DKD glomerular and tubular kidney biopsy tissues were compared with normal tissues, and were analyzed using the limma package. Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed for DEGs using the GO Function software in Bioconductor. The protein‑protein interaction (PPI) network was then constructed using Cytoscape software. A total of 426 genes (115 up‑ and 311 downregulated) were differentially expressed between the DKD and normal tissue samples. The PPI network was constructed with 184 nodes and 335 edges. Vascular endothelial growth factor A (VEGFA), α‑actinin‑4 (ACTN4), proto‑oncogene, Src family tyrosine kinase (FYN), collagen, type 1, α2 (COL1A2) and insulin‑like growth factor 1 (IGF1) were hub proteins. Major histocompatibility complex, class II, DP α1 (HLA‑DPA1) was the common gene enriched in the rheumatoid arthritis and systemic lupus erythematosus pathways, and the immune response was a GO term enriched in module A. VEGFA, ACTN4, FYN, COL1A2, IGF1 and HLA‑DPA1 may be potential key genes associated with the progression of DKD, and immune mechanisms may serve a part in DKD development.
Figures



Similar articles
-
Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.Front Endocrinol (Lausanne). 2022 Jun 3;13:883658. doi: 10.3389/fendo.2022.883658. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721731 Free PMC article.
-
Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.PeerJ. 2022 Sep 20;10:e13932. doi: 10.7717/peerj.13932. eCollection 2022. PeerJ. 2022. PMID: 36157062 Free PMC article.
-
Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.Front Endocrinol (Lausanne). 2022 May 12;13:880930. doi: 10.3389/fendo.2022.880930. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35634488 Free PMC article.
-
MicroRNA: a novel biomarker and therapeutic target to combat autophagy in diabetic nephropathy.Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6257-6263. doi: 10.26355/eurrev_201907_18446. Eur Rev Med Pharmacol Sci. 2019. PMID: 31364128 Review.
-
Perspectives on systems biology applications in diabetic kidney disease.J Cardiovasc Transl Res. 2012 Aug;5(4):491-508. doi: 10.1007/s12265-012-9382-7. Epub 2012 Jun 26. J Cardiovasc Transl Res. 2012. PMID: 22733404 Free PMC article. Review.
Cited by
-
Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy.Biomed Res Int. 2022 May 10;2022:9554658. doi: 10.1155/2022/9554658. eCollection 2022. Biomed Res Int. 2022. PMID: 35592524 Free PMC article.
-
Identification of Potential Drug Targets for Immunoglobulin A Nephropathy: A Mendelian Randomization Study.Biomedicines. 2025 Feb 25;13(3):581. doi: 10.3390/biomedicines13030581. Biomedicines. 2025. PMID: 40149558 Free PMC article.
-
Epigallocatechin Gallate Induces the Demethylation of Actinin Alpha 4 to Inhibit Diabetic Nephropathy Renal Fibrosis via the NF-KB Signaling Pathway In Vitro.Dose Response. 2022 Jun 10;20(2):15593258221105704. doi: 10.1177/15593258221105704. eCollection 2022 Apr-Jun. Dose Response. 2022. PMID: 35706474 Free PMC article.
-
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease.Diabet Med. 2025 Feb;42(2):e15447. doi: 10.1111/dme.15447. Epub 2024 Oct 26. Diabet Med. 2025. PMID: 39460977 Free PMC article. Review.
-
Identification of genetic variants associated with diabetic kidney disease in multiple Korean cohorts via a genome-wide association study mega-analysis.BMC Med. 2023 Jan 11;21(1):16. doi: 10.1186/s12916-022-02723-4. BMC Med. 2023. PMID: 36627639 Free PMC article.
References
-
- Levin A, Rocco M. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12–S154. - PubMed
-
- Langham RG, Kelly DJ, Cox AJ, Thomson NM, Holthöfer H, Zaoui P, Pinel N, Cordonnier DJ, Gilbert RE. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition. Diabetologia. 2002;45:1572–1576. doi: 10.1007/s00125-002-0946-y. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous